Effect of Smilax china L.-containing serum on the expression of POLD1 mRNA in human hepatocarcinoma SMMC-7721 cells

Experimental and Therapeutic Medicine

Volumn 6, Issue 4, 2013, Pages 1070-1076

  Cao, Bo ^a   Zhang, Zihan ^a   Zhang, Yuqin ^a   Li, Jiaquan ^b   Liang, Gang ^a   Ling, Jianghong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Experimental Center for Medical Sciences   (China)

Author keywords

Drug containing serum; POLD1; Smilax china L.; SMMC 7721 human hepatocarcinoma cell

Indexed keywords

CYCLOPHOSPHAMIDE; DNA DIRECTED DNA POLYMERASE DELTA; PLANT EXTRACT; SMILAX CHINA EXTRAXCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; RAT;

EID: 84883239755     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1264     Document Type: Article

References (27)

1. Liang QC and Zhong M (eds): China Zhuang nationality medicine. Guangxi Nationalities Publishing House, Nanning, p226, 2005.
2. Wei JY, Li Y, Wei T, et al: Drug screening study of 50 kinds of Chinese herbal and zhuang nationality medicine in guangxi. J Guangxi Traditional Chinese Med Univ 4: 3-7, 2003 (In Chinese).
3. Xu Y, Wang HY, Jiang JY, et al: Studies on steroidal saponins from Smilax china and their cytotoxic activities. Chinese J Experimental Traditional Med Formulae 11: 92-96, 2011 (In Chinese).
4. Jiang LY and Liu YM: Study on the relationship between structures and anti-tumor activity of flavonoids compounds. Computers and Applied Chemistry 4: 21-24, 2005.
5. Kohn K W, Aladjem MI, Weinstein JN and Pommier Y: Chromatin challenges during DNA replication: a systems representation. Mol Biol Cell 19: 1-7, 2008.
6. Zhang K and Ma SL: Progress on anticancer molecule mechanism of naturally occurring drugs. China Journal of Traditional Chinese Medicine and Pharmacy 10: 2344-2347, 2011 (In Chinese).
7. Lepley DM, Li B, Birt DF and Pelling JC: The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375, 1996.
8. Ou XH, Liao LF, Liu HG and Xu H: Significance of POLD1 expression in primary hepatocellular carcinoma. World Chin J Digestology 19: 151-155, 2011 (In Chinese).
9. Yan YQ (ed): The Ideas and Methods of Modern Research of Traditional Chinese Medicine. Chemical Industry Press, Beijing, pp340-341, 2006.
10. Li F, Li SL and Yin YG: Construction of NK4 recombinant lentiviral vector and its expression in HCCLM3 cells. J Chin Med Univ 40: 1081-1084, 2011 (In Chinese).
11. Zhao YQ and Zhe ZF: Advances in gene Treatment of Primary hepatic carcinoma. Disease Monitor and Control 8: 482-484, 2011, (In Chinese).
12. Lin XY, Zhang SR and Xu H: Advances of Eukaryotic DNA polymerase δ. Progress in Natural Science 1: 3-9, 2005 (In Chinese).
13. Ruan XL, Li YL and Wu Q: P21 suppresses cell proliferation and downregulates POLD1 expression in human gastric cancer cell line MGC-803. World Chin J Digestology 19: 1990-1995, 2011 (In Chinese).
14. Liao ZJ, Zhang XM, Guo YH and Sun HF: Study on the effect of proliferation and apoptosis of sarsasapogenin to human gastric cancer line BGC-823. Modern Oncology 18: 1085-1087, 2010 (In Chinese).
15. Huang CH, Lu Y, Gao XJ, et al: Advances of serum pharmacology of Chinese medicine. Chin J Exp Trad Med Formulae 17: 266-271, 2011 (In Chinese).
16. 10 kinds of Zhuang medicine-containing serum against human hepatocellular carcinoma cells' effect and the study of Jingangteng-containing serum affect the tumor suppressor gene WWOX's expression. Dissertation of Guangxi Med Univ: 14, 2012 (In Chinese).
17. Chinese Pharmacopoeia Commission (ed): Pharmacopoeia of People's Republic of China. Beijing Chemical Industry Press, p216, 2005.
18. Zeng XX and Chen XL: Advances of traditional application and modern research of Smilax china L. Chinese Traditional and Herbal Drugs 6: 952-954, 2008.
19. Wang XJ: Phenolic constituents from Smilax china L and their antitumor activities. Dissertation of Nanjing University of Science & Technology: 23, 2009 (In Chinese).
20. Li Y, Yao LB, Wang LF, et al: Inducing effect of resveratrol on anoikis of gastric cancer cells. Chinese Traditional and Herbal Drugs 10: 64-66, 2004.
21. Luo Q, Song GB, Qin J, et al: Progress of research on hepatocellular carcinoma cells apoptosis induced by Chinese traditional medicine. Journal of Chongqing Univ 7: 115-117, 2005.
22. Li GC, Dong KL and Hu CH: Effect of compound Rhizoma Smilacinus granules on the expression of Bcl-2 and Bax gene in A549 cell lines of non-small cell lung cancers. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32: 312-315, 2007 (In Chinese).
23. Xu W: Anti-proliferative effect on tumor cells of kaempferol-7-O-β-D-glucoside isolated from Smilax china L. Rhizome. Dissertation of East China University of Science and Technology: 42, 2008 (In Chinese).
24. Sanefuji K, Taketomi A, Iguchi T, et al: Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinoma. Oncology 79: 229-237, 2010.
25. Xiaoyan L, Shuren Z and Heng X: Eukaryotic DNA polymerase δ research present situation. J Prog Nat Sci 17: 716-723, 2007.
26. Hansen K, Farkas T, Lukas J, et al: Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block. EMBO J 20: 422-432, 2001.
27. Song N, Zhu X, Shi L, et al: Identification and functional analysis of a CDE/CHR element in the POLD1 promoter. Sci China C Life Sci 52: 551-559, 2009.